LENZ Therapeutics (LENZ) Current Leases (2021 - 2023)

LENZ Therapeutics (LENZ) has 3 years of Current Leases data on file, last reported at $285000.0 in Q4 2023.

• On a quarterly basis, Current Leases fell 92.95% year-over-year to $285000.0 in Q4 2023; TTM through Dec 2023 was $285000.0, a 92.95% decrease from a year earlier, with the FY2023 full-year figure at $285000.0, down 92.95% from the prior year.
• Current Leases for Q4 2023 stood at $285000.0, down from $3.4 million in the prior quarter.
• Over the last five years, Current Leases for LENZ reached as high as $5.6 million in Q1 2022 and fell as low as $285000.0 in Q4 2023.
• Historically, Current Leases has averaged $3.9 million across 3 years, with a median of $4.3 million in 2022.
• Across the five-year window, Current Leases retreated 4.29% in 2022 and tumbled 92.95% in 2023, its largest moves.
• Year by year, Current Leases stood at $5.5 million in 2021, then retreated by 26.21% to $4.0 million in 2022, then tumbled by 92.95% to $285000.0 in 2023.
• Per Business Quant data, the three most recent Current Leases figures were $285000.0 in Q4 2023, $3.4 million in Q3 2023, and $2.9 million in Q2 2023.